Sky Century Investment (SKYI) Accounts Payables (2013 - 2026)
Sky Century Investment's (SKYI) quarterly Accounts Payables came in at $2432.0 in Q2 2026, down 94.81% year-on-year from $46847.0 in Q2 2025, and down 64.11% on a QoQ basis from $6777.0 in Q1 2026.
Sky Century Investment (SKYI) Accounts Payables (2013 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has 5 years of Accounts Payables data on file, last reported at $2432.0 in Q2 2026.
- On a quarterly basis, Accounts Payables fell 94.81% year-over-year to $2432.0 in Q2 2026; TTM through May 2026 was $2432.0, a 94.81% decrease from a year earlier, with the FY2025 full-year figure at $28794.0, changed 0.36% from the prior year.
- Accounts Payables for Q2 2026 stood at $2432.0, down from $6777.0 in the prior quarter.
- Over the last five years, Accounts Payables for SKYI reached as high as $46847.0 in Q2 2025 and fell as low as $2432.0 in Q2 2026.
- Historically, Accounts Payables has averaged $22814.5 across 3 years, with a median of $25967.0 in 2025.
- Across the five-year window, Accounts Payables dropped 0.36% in 2025 and tumbled 94.81% in 2026, its largest moves.
- Year by year, Accounts Payables stood at $28897.0 in 2024, then declined by 19.92% to $23140.0 in 2025, then tumbled by 89.49% to $2432.0 in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $2432.0 in Q2 2026, $6777.0 in Q1 2026, and $23140.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Sky Century Investment | 1.06 Mn | 1.06 Mn | 26,045.00 | 2,432.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 2,432.00 |
| Feb 28, 2026 | 6,777.00 |
| Nov 30, 2025 | 23,140.00 |
| Aug 31, 2025 | 28,794.00 |
| May 31, 2025 | 46,847.00 |
| Aug 31, 2024 | 28,897.00 |
| Aug 31, 2014 | 14,880.00 |
| May 31, 2014 | 6,450.00 |
| Feb 28, 2014 | 2,000.00 |
| Nov 30, 2013 | 2,300.00 |
| Aug 31, 2013 | 2,500.00 |
| May 31, 2013 | 4,000.00 |